Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

0.390
+0.0051.30%
Volume:292.00K
Turnover:115.25K
Market Cap:241.02M
PE:-0.80
High:0.410
Open:0.370
Low:0.370
Close:0.385
52wk High:5.830
52wk Low:0.330
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:1.47
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.490
ROE:-242.61%
ROA:-18.75%
PB:-14.83
PE(LYR):-0.80
PS:- -

Loading ...

IMMUNOTECH-B Reports Half-Year Results with Narrowed Loss

Stock News
·
Aug 21

Immunotech Biopharm FY26 H1 Net Loss Narrows 45.8% to RMB 69.87 Million

Reuters
·
Aug 21

Apichope's Subsidiary Gains Regulatory Nod for Novel Drug Trial Application

Stock News
·
Aug 21

When This Sector Rallies, Tech Takes a Backseat

Deep News
·
Aug 21

Daily ETF Wrap: Innovative Drugs and CXO Remain the Two Brightest Investment Themes in the Healthcare Sector

Deep News
·
Aug 20

Unexpected Surge: Moderna Jumps 177% on Historic Cancer Vaccine Breakthrough, Sending ASX and Hong Kong Biotech Stocks Soaring

Deep News
·
Aug 20

The Real Market Driver Right Now Might Surprise You

Deep News
·
Aug 20

Hong Kong Stock Market Flash | SIMCERE PHARMA (02096) Surges Over 5% in Morning Session Ahead of Interim Results Release

Stock News
·
Aug 20

Record Earnings From Industry Leaders Signal Peak Season for Innovative Drug Mid-Year Reports?

Deep News
·
Aug 20

Hengrui Pharma's First-Half Results Unveil Strategic Shifts: From Innovative Drugs to NewCo Expansion

Stock News
·
Aug 19

This Sector Is Experiencing a Major Surge

Deep News
·
Aug 19

What We're Really Talking About When We Discuss Innovative Drugs Today

Deep News
·
Aug 19

Rising Momentum in Innovative Drug Sector: Is the Rally Sustainable?

Deep News
·
Aug 19

Hong Kong Stock Market Flash | Micot Pharma-B (02335) Surges Nearly 6% in Afternoon Session as Innovative Drug XTL6001 Makes Third Appearance on International Academic Stage

Stock News
·
Aug 18

Jiangsu Nhwa Pharmaceutical's Innovative Drug NH302 Injection Cleared for Clinical Trials

Stock News
·
Aug 18

Innovative Drug Sector's Rally from Lows Faces Divergence as Sustainability Hinges on Commercialization Proof

Deep News
·
Aug 16

Three Major Cross-Border Deals Land on Same Day, Boosting Sentiment for Chinese Innovative Drug Outbound Licensing; T+0 Huatai Baorui Hang Seng Innovative Drug ETF (520500) Attracts Over 2.5 Billion Yuan in Net Inflows Over the Past Year

Deep News
·
Aug 13

Three Emerging Export Sectors: How Many Does Nanjing Jiangbei New Area Command?

Deep News
·
Aug 12

Yiling Receives Notice for Clinical Trial Application of Its New Chemical Drug 'LB220-D08 Extended-Release Tablets'

Stock News
·
Aug 12

Haisco Pharmaceutical Group Receives Clinical Trial Approval for Novel Drug HSK60002 Tablet

Stock News
·
Aug 12